Results 171 to 180 of about 2,743,257 (209)
Some of the next articles are maybe not open access.

HCV Core Antigen Testing versus HCV PCR Testing for Early Detection of HCV Infection

The Egyptian Journal of Medical Microbiology, 2014
HCV core antigen is detectable in serum several weeks earlier than anti-HCV antibodies. Variability in early detection time is even more pronounced in certain groups of patients such as the hemodialysis and immunocompromised where the antibody response may take between 45-68 days to develop.
Baha Abdalhamid   +2 more
openaire   +1 more source

Quantitative Measurement of HCV Core Antigen for Management of Interferon-Free Therapy in HCV-Infected Patients

Antiviral Therapy, 2018
Background According to current recommendations diagnosis and management of HCV infection need detection and quantification of nucleic acids. In the era of direct-acting antivirals (DAA) it is essential to develop an inexpensive and simple method replacing polymerase chain reaction.
Mariusz, Łucejko, Robert, Flisiak
openaire   +2 more sources

Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication

Hepatology, 2002
Hepatitis C virus (HCV) RNA detection, viral load quantification, and HCV genotyping are widely used in clinical practice. Recently, the availability of an anticore antigen (Ag) monoclonal antibody allowed development of an enzyme-linked immunosorbent assay (ELISA) detecting and quantifying total HCV core Ag in peripheral ...
Magali, Bouvier-Alias   +11 more
openaire   +2 more sources

HCV Core Antigen and Combination (Antigen/Antibody) Assays for the Detection of Early Seroconversion

Journal of Medical Virology, 2007
Detection of antibodies against hepatitis C virus (HCV) and/or detection of HCV RNA by nucleic acid testing (NAT) are the commonly utilized methods for detecting exposure to HCV in both blood screening and diagnostic laboratories. While several HCV core antigen tests have been developed over the last 10 years, these assays have not gained wide ...
George J Dawson
exaly   +2 more sources

HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis

Journal of Clinical Virology, 2012
A quantitative HCV core antigen (HCVcoreAg) immunoassay has been developed for the confirmation of viremia in patients with hepatitis C.We evaluated the correlation of HCV RNA and HCVcoreAg in different patient populations without HCV-specific treatment: HIV/HCV-coinfection, HBV/HCV-coinfection, and patients with end-stage renal disease.HCVcoreAg was ...
Ingmar, Mederacke   +7 more
openaire   +2 more sources

HCV core antigen detection in seropositive samples

Journal of Medical Virology, 2007
Detection of antibodies to HCV is typically the primary test utilized to identify HCV-infected individuals. Seropositive individuals may then be tested for HCV RNA by nucleic acid testing (NAT) to determine if the individual is actively infected with HCV.
openaire   +1 more source

HCV core antigen and the time of HCV infection

2004
Backgroung: antibody tests are unable to identify subjects in the early stage of infection (window period) during which specific antibodies have not yet been produced. This stage (preseroconversion period) may last up to 2 months in immunocompetent and as long as 6 to 12 months in immunodeficient patients.
Burek, Vitomir, Mikulić, Radojka
openaire   +1 more source

[Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2013
Currently, in the diagnosis and monitoring of treatment of HCV infection are used molecular biology methods to detect HCV genetic material and which are based on the polymerase chain reaction (PCR). Due to limitations in the application of this method, such as expensiveness and labor intensive, the alternative might be quantification of HCV core ...
Mariusz, Łucejko   +3 more
openaire   +1 more source

Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C

Journal of Clinical Virology, 2013
An early drop of HCV-RNA levels is useful in assessing response to antiviral treatment in chronic hepatitis C; the first recommended time point is 4 weeks after the start of therapy.We evaluated retrospectively HCV-RNA and HCVAg levels at different time points to assess the clinical value of an early monitoring.Thirty-five patients with chronic ...
LOGGI, ELISABETTA   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy